Efficacy and Safety of Exercise Training in Patients With Chronic Heart FailureChristopher M. O’Connor, for the HF-ACTION Investigators, David J. Whellan et al.|JAMA|2009Cited by 2.2k
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 YearsJeff D. Williamson, Nicholas M. Pajewski, Marie Krousel‐Wood et al.|JAMA|2016Cited by 1.2k
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trialHiddo J.L. Heerspink, Chris Vercammen, Hans‐Henrik Parving et al.|The Lancet|2019Cited by 609
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trialMichael E. Nassif, Mikhail Kosiborod, Sheryl L. Windsor et al.|Nature Medicine|2021Cited by 599
Age-Related Changes in Normal Human Hearts During the First 10 Decades of Life. Part II (Maturity): A Quantitative Anatomic Study of 765 Specimens From Subjects 20 to 99 Years OldDalane W. Kitzman, William D. Edwards, DAVID G. SCHOLZ et al.|Mayo Clinic Proceedings|1988Cited by 502